Fred Alger Management, LLC Boston Scientific Corp Transaction History

Fred Alger Management, LLC

$20.2 Billion
Q2 2025

A detailed history of Fred Alger Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Fred Alger Management, LLC holds 987,969 shares of BSX stock, worth $99.4 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

987,969

Previous 975,603 1.27%

Holding current value

$99.4 Million

Previous $98.4 Million 7.82%

% of portfolio

0.52%

Previous 0.6%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$89.7 - $107.41 $1.11 Million - $1.33 Million	12,366 Added 1.27%	987,969 $106 Million
Q1 2025 May 15, 2025	SELL	$89.38 - $106.18 $35.5 Million - $42.2 Million	-397,418 Reduced 28.94%	975,603 $98.4 Million
Q4 2024 Feb 14, 2025	SELL	$83.62 - $91.5 $34.8 Million - $38.1 Million	-415,971 Reduced 23.25%	1,373,021 $123 Million
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $17.9 Million - $20.6 Million	-245,570 Reduced 12.07%	1,788,992 $150 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $11.7 Million - $13.5 Million	-173,087 Reduced 7.84%	2,034,562 $157 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $693,792 - $826,527	-12,045 Reduced 0.54%	2,207,649 $151 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $18.3 Million - $21.8 Million	-376,778 Reduced 14.51%	2,219,694 $128 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $27 Million - $29.4 Million	537,992 Added 26.14%	2,596,472 $137 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $2.9 Million - $3.19 Million	58,323 Added 2.92%	2,058,480 $111 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $36.7 Million - $40.7 Million	813,771 Added 68.59%	2,000,157 $100 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $46.9 Million - $56 Million	1,186,386 New	1,186,386 $54.9 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $5.06 Million - $5.63 Million	-122,606 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $12.8 Million - $14.7 Million	-332,519 Reduced 73.06%	122,606 $5.24 Million
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $2.39 Million - $2.68 Million	67,644 Added 17.46%	455,125 $17.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $313 Million - $397 Million	-9,447,559 Reduced 96.06%	387,481 $13.9 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $542,464 - $665,164	-15,751 Reduced 0.16%	9,835,040 $376 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $25 Million - $32.4 Million	828,880 Added 9.19%	9,850,791 $346 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $27.7 Million - $49.1 Million	1,073,710 Added 13.51%	9,021,911 $294 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $81.5 Million - $97.7 Million	-2,153,158 Reduced 21.32%	7,948,201 $359 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $11.8 Million - $12.7 Million	-293,251 Reduced 2.82%	10,101,359 $411 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $12.9 Million - $15.8 Million	368,412 Added 3.67%	10,394,610 $447 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $106 Million - $131 Million	-3,222,479 Reduced 24.32%	10,026,198 $385 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $164 Million - $202 Million	5,179,308 Added 64.18%	13,248,677 $468 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $76.5 Million - $90 Million	2,329,670 Added 40.59%	8,069,369 $311 Million
Q2 2018 Jul 19, 2018	BUY	$26.84 - $34.32 $23.9 Million - $30.5 Million	888,982 Added 18.33%	5,739,699 $188 Million
Q1 2018 May 10, 2018	BUY	$25.2 - $28.54 $41.1 Million - $46.6 Million	1,631,130 Added 50.66%	4,850,717 $133 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $37.8 Million - $45.4 Million	-1,523,073 Reduced 32.11%	3,219,587 $79.8 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $125 Million - $138 Million	4,742,660	4,742,660 $138 Million

Others Institutions Holding BSX

# of Institutions

1,932

Shares Held

1.27B

Call Options Held

9.59M

Put Options Held

7.17M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $144B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Boston Scientific Corp Transaction History